News - Viread

Filter

Current filters:

Viread

Popular Filters

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

Gilead and Teva settle Viread patent litigation

20-02-2013

US biotech firm Gilead Sciences (Nasdaq: GILD), a global leader in the HIV/AIDS drug market, has reached…

Anti-viralsBiotechnologyGenericsGilead SciencesNorth AmericaPatentsTeva Pharmaceutical IndustriesViread

FDA backs Gilead’s Viread for children

20-01-2012

The US Food and Drug Administration has approved US biotech firm Gilead Sciences (Nasdaq: GILD) Viread…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationViread

New research shows Gilead’s ARVs prevent HIV infection in heterosexuals

14-07-2011

Results from two African studies of pre-exposure prophylaxis, or PrEP, released yesterday well ahead…

Anti-viralsGilead SciencesPharmaceuticalResearchTruvadaViread

Gilead to boost HIV/hep B drug access via link with Medicine Patent Pool

12-07-2011

The Medicines Patent Pool (which was set up in 2010 by UNITAID)revealed this morning that it has entered…

Anti-viralscobicistatelvitegravirEmtrivaGilead SciencesMarkets & MarketingPharmaceuticalViread

Back to top